News
Your License Is a Failure Point: Why State Renewals Are High-Stakes
For many pharmaceutical and medical device companies, state licensing has historically been treated as a routine administrative function. Applications are submitted, renewals are tracked, and documentation is filed away until the next cycle. It has been a predictable...
The FDA Has Drawn a Line in the Sand on DSCSA Compliance
The message is no longer subtle. It is not a warning shot. It is enforcement. A recent action involving U.S. Food and Drug Administration and Pure Indulgence Aesthetics has fundamentally changed the tone around the Drug Supply Chain Security Act. What was once...
The AI Illusion in Pharma Compliance: Why Human Expertise Still Runs the Show
There’s no question that technology is reshaping the pharmaceutical industry. From advanced analytics to AI-driven automation, the promise is compelling: faster workflows, lower costs, and fewer manual errors. In licensing and regulatory compliance, that...
Beyond the Checklist: Why Your Pharmaceutical Compliance Strategy is Failing (and How to Fix It)
If you manage licensing and pharmaceutical compliance for a life sciences or medical device firm, you know the "Sunday Scaries" of the industry: a patchwork of spreadsheets, creeping renewal deadlines, and the constant, low-grade fever of evolving DSCSA requirements....
Beyond Your Home State: Why Proactive Licensing Strategy Is Becoming a Competitive Imperative for CMOs and CDMOs
For Contract Manufacturing Organizations (CMOs) and Contract Drug Manufacturing Organizations (CDMOs), licensing has traditionally been viewed as a requirement tied to physical operations. If you manufacture, repackage, or distribute from a specific state, you...
The FDA Is Moving to a 12-Digit NDC Format. What This Means for the Pharmaceutical Supply Chain
The FDA recently finalized a rule that will reshape one of the most widely used identifiers in the pharmaceutical industry: the National Drug Code (NDC). Through its final rule, “Revising the National Drug Code Format and Drug Label Barcode Requirements,” the agency...
Trading Partner Verification Under DSCSA: Why Compliance Teams Can No Longer Afford to Treat It as a Check-the-Box Exercise
Strengthen DSCSA compliance with effective trading partner verification. Learn why continuous license monitoring, audit-ready documentation, and proactive processes are critical to avoiding risk and ensuring regulatory compliance.
Proactive Compliance: How PharmaRegs Streamlines Licensing Workflows for Internal Teams
State licensing requirements continue to evolve across the pharmaceutical and medical device landscape. New rules, updated interpretations, revised application forms, and changing renewal timelines can all affect a company’s ability to operate compliantly. For...
License Renewals Are Not Just Administrative: The Cost of Getting Them Wrong
For pharmaceutical manufacturers, wholesale distributors, 3PLs, repackagers, reverse distributors, and medical device companies, state license renewals are often viewed as routine paperwork. A deadline to track. A form to submit. A fee to pay. But in reality, state...








